In addition, this study suggested that PBMC LMP7 at admission possessed limited capability for reflecting risk of disability, recurrence, or death; while PBMC LMP7 at discharge exhibited a weak ability for evaluating disability but a better capacity for estimating recurrence and death in AIS patients. The gene discussed is PSMB8; the disease is androgen insensitivity syndrome.